Adding to its existing MassARRAY portfolio.

UltraSEEK assays can assess up to 10 genetic loci per well, producing UltraSEEK the just multiplex methodology for sensitive analysis of liquid biopsies. Labs that choose the MassARRAY 24-Well Program can, as assessment volumes expand, update the instrument to support 96 – or 384-well platforms for improved throughput. The MassARRAY program is research only use. The U.S.. Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing Agena Bioscience today released the MassARRAY 24-Good System for mass spectrometry-based genetic analysis, adding to its existing MassARRAY portfolio.Griffiths, M.D., Kim Papp, M.D., Ph.D.D., Ph.D., Hidemi Nakagawa, M.D., Ph.D., Lynda Spelman, M.B., B.S.D., Ph.D., Enrique Rivas, M.D., Tsen-Fang Tsai, M.D., Norman Wasel, M.D., Stephen Tyring, M.D., Ph.D., Thomas Salko, B.A., Isabelle Hampele, Ph.D., Marianne Notter, M.S., Alexander Karpov, Ph.D., Silvia Helou, M.D., Ph.D., and Charis Papavassilis, M.D., Ph.D.1,2 Our understanding of the pathogenesis of psoriasis was advanced by the discovery of the course of type 17 helper T cells, which regulates innate and adaptive immunity.3-7 Interleukin-17A stimulates keratinocytes to secrete chemokines and other proinflammatory mediators that recruit extra inflammatory cells, including neutrophils, Th17 cells, dendritic cells, and innate lymphoid cells.8-10 Interleukin-17A thus potentially acts as a get better at cytokine in the pathogenesis of psoriasis.